Editas Medicine wins CRISPR patent ruling from USPTO
Go back to Editas Medicine wins CRISPR patent ruling from USPTO| (NASDAQ: EDIT) | Delayed: 3.01 +0.23 (8.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $43.99 | |||
| Open | $2.78 | 52 Week Low | $12.43 | |||
| Day High | $3.13 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $0.00 | |||
| Volume | 1,909,730 | |||||
